These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6145777)

  • 1. The opioid kappa-selective compound U-50,488H does not inhibit intestinal propulsion in rats.
    Tavani A; Gambino MC; Petrillo P
    J Pharm Pharmacol; 1984 May; 36(5):343-4. PubMed ID: 6145777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig.
    Culpepper-Morgan J; Kreek MJ; Holt PR; LaRoche D; Zhang J; O'Bryan L
    Life Sci; 1988; 42(21):2073-7. PubMed ID: 2838706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperalgesic effect of the selective kappa opioid agonist, U-50488H in mice.
    Ramabadran K
    Jpn J Pharmacol; 1983 Dec; 33(6):1289-92. PubMed ID: 6321836
    [No Abstract]   [Full Text] [Related]  

  • 6. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists.
    Von Voigtlander PF; Lewis RA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):467-70. PubMed ID: 6298890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
    Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
    Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M; Senda T; Kaneto H
    Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
    Shook JE; Pelton JT; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
    Bhargava HN; Matwyshyn G; Ramarao P
    Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN; Ramarao P; Gulati A
    Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective opioid agonists on feline colonic transit.
    Krevsky B; Cowan A; Maurer AH; Butt W; Fisher RS
    Life Sci; 1991; 48(16):1597-602. PubMed ID: 1850059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu and kappa opioid modulation of olfactory bulb evoked potentials.
    Pérez H; Hernández A; Inostroza H
    Int J Neurosci; 1989 Dec; 49(3-4):329-32. PubMed ID: 2561634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
    Ukai M; Kameyama T
    Brain Res; 1985 Jul; 337(2):352-6. PubMed ID: 2992682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo.
    Hirning LD; Porreca F; Burks TF
    Eur J Pharmacol; 1985 Feb; 109(1):49-54. PubMed ID: 2986990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.